Biography:

Dr. Srikanth Sadhu is a Research Scientist at the Translational Health Science and Technology Institute (THSTI), India, where his research focuses on host–pathogen interactions, immune regulation, antiviral drug discovery, and cancer immunotherapy. His work has advanced the understanding of viral immunopathogenesis and the development of therapeutics against emerging pathogens, including coronaviruses and dengue virus. He has published in leading journals such as Nature Communications, eLife, Antiviral Research, and iScience. Dr. Sadhu serves on the Executive Committee of the Indian Immunology Society and was recently recognized as an IUIS Rising Star and a TouchIMMUNOLOGY Future Leader 2026.